je.st
news
BPCIA: Amgen Begins the Patent Dance With AbbVie
2015-12-08 00:56:18| Biotech - Topix.net
On November 25, 2015, Amgen Inc. announced it submitted its first biologics license application to the FDA under the Section 351 biosimilar approval pathway provided in the Biologics Price Competition and Innovation Act . Amgen's BLA seeks approval for its biosimilar of AbbVie's top-selling arthritis drug Humira .
Tags: dance
begins
patent
amgen
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||